Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Israel Journal of Health Policy Research
Published in: Israel Journal of Health Policy Research 1/2020

01-12-2020 | Tuberculosis | Original research article

Tuberculosis treatment outcomes of non-citizen migrants: Israel compared to other high-income countries

Authors: D. Chemtob, E. Ogum

Published in: Israel Journal of Health Policy Research | Issue 1/2020

Login to get access

Abstract

Background: In TB low incidence countries, the outcome of TB treatment among non-citizen migrants from endemic countries affects ability to eliminate TB. This study compares TB treatment outcomes among non-citizen migrants in select pre-elimination country based on their policies for non-citizen migrant TB patients in order to determine how policy affects TB outcomes.

Methods

A literature review was conducted via PUBMED, MEDLINE (2000–2017) on TB policy among non-citizen migrants and treatment outcome. Treatment outcome among migrants diagnosed in Israel during 2000–2014 was analysed.

Results

In total, 18 publications met the inclusion criteria. All the countries reviewed except the United States offered free TB treatment to undocumented migrants. Successful TB treatment outcome for non-citizen migrants in Israel was 87%, the Netherlands was 90.7%, the UK was 82.1%, and outcomes in the US and Australia were not published.

Conclusions

There is a need to standardize results based on international definitions of migrants, asylum seekers, and refugees in order to determine status-specific barriers and to facilitate international comparisons. Policies insuring free access to TB care for non-citizen migrants are an important element for TB elimination in low incidence countries.
Literature
1.
Kronfol N, Mansour Z. Tuberculosis and migration: a review/Tuberculose et migration: analyse. East Mediterr Health J. 2013;19(8):739.CrossRef
2.
Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, De Vries G, Diel R, et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J. 2015;45(4):928–52.CrossRef
3.
Chemtob D, Leventhal A, Berlowitz Y, Weiler-Ravell D. The new National Tuberculosis control programme in Israel, a country of high immigration. Int J Tuberc Lung Dis. 2003;7(9):828–36.PubMed
4.
Chemtob D, Leventhal A, Weiler-Ravell D. Screening and management of tuberculosis in immigrants: the challenge beyond professional competence. IJTLD. 2003;7(10):959–66.
5.
Heldal E, Kuyvenhoven J, Wares F, Migliori G, Ditiu L, Fernandez De La Hoz K, et al. Diagnosis and treatment of tuberculosis in undocumented migrants in low-or intermediate-incidence countries [workshop report]. IJTLD. 2008;12(8):878–88.
6.
Mor Z, Kolb H, Lidji M, Migliori G, Leventhal A. Tuberculosis diagnostic delay and therapy outcomes of non-national migrants in Tel Aviv, 1998-2008. Eurosurveillance. 2013;18(12):e20433.
7.
8.
9.
de Vries G, van Hest R, Bakker M, Erkens C, van den Hof S, Meijer W, et al. Policy and practice of programmatic management of latent tuberculosis infection in the Netherlands. J Clin Tuberc Other Mycobact Dis. 2017;7:40–8.CrossRef
10.
11.
Dara M, Sulis G, Centis R, D'Ambrosio L, De Vries G, Douglas P, et al. Cross-border collaboration for improved tuberculosis prevention and care: policies, tools and experiences. IJTLD. 2017;21(7):727–36.CrossRef
12.
Dara M, Solovic I, Sotgiu G, D'Ambrosio L, Centis R, Tran R, et al. Tuberculosis care among refugees arriving in Europe: an ERS/WHO Europe region survey of current practices. Eur Respir J. 2016;48(3):808–17.CrossRef
13.
Kunst H, Burman M, Arnesen T, Fiebig L, Hergens M, Kalkouni O, et al. Tuberculosis and latent tuberculous infection screening of migrants in Europe: a comparative analysis of policies, surveillance systems and results. IJTLD. 2017;21(8):840–51.CrossRef
14.
Zimmerman C, Kiss L, Hossain M. Migration and health: a framework for 21st-century policy-making. PLoS Med. 2011;8(5):e1001034.CrossRef
15.
16.
Alvarez GG, Gushulak B, Rumman KA, Altpeter E, Chemtob D, Douglas P, et al. A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates. BMC Infect Dis. 2011;11(1):3.CrossRef
17.
Chemtob D, Mor Z, Grotto I. Tuberculosis screening programmes for migrants to low-incidence countries—the Israeli experience. Lancet Infect Dis. 2015;15(8):876.CrossRef
18.
Correa-Velez I, Gifford SM, Bice SJ. Australian health policy on access to medical care for refugees and asylum seekers. Aust N Z Health Policy. 2005;2(1):23.CrossRef
19.
Odone A, Tillmann T, Sandgren A, Williams G, Rechel B, Ingleby D, et al. Tuberculosis among migrant populations in the European Union and the European economic area. Eur J Pub Health. 2014;25(3):506–12.CrossRef
20.
Eziefula AC, Sa M, Brown M. The health of recent migrants from resource-poor countries. Medicine. 2014;42(2):112–7.CrossRef
21.
22.
23.
La’Marcus TW, Coleman MS, de la Motte HC, Semple M, Zhou W, Cetron MS, et al. A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program. BMC Pub Health. 2015;15(1):1201.CrossRef
24.
Lönnroth K, Mor Z, Erkens C, Bruchfeld J, Nathavitharana R, van der Werf M, et al. Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points. IJTLD. 2017;21(6):624–36.CrossRef
25.
26.
Van den Bosch C, Roberts J. Tuberculosis screening of new entrants; how can it be made more effective? J Public Health. 2000;22(2):220–3.CrossRef
27.
World Health Organization. Excutive Board 134. Global strategy and targets for tuberculosis prevention, care and control after 2015. Draft resolution proposed by Australia, Brazil, Colombia, Costa Rica, Estonia, France, Italy, Japan, Netherlands, Poland, Portugal, Slovakia, South Africa, and the United States of America. 2014. Available from: https://​apps.​who.​int/​iris/​handle/​10665/​172989. Date accessed 30 Apr 2017.
28.
Eziefula C, Brown M. The health of recent migrants from resource-poor countries. Medicine. 2010;38(1):60–5.CrossRef
29.
30.
Balaban, V. Marks, S. Etkind, S. Katz, D. Higashi, J. Flood, J. et. al. Tuberculosis elimination efforts in the United States in the era of insurance expansion and the affordable care act. Publc Health Reports 2015. 190 (July-August 2015): 349–354.
31.
Davidow, A. Katz, D. Ghosh, S. Blumberg, H. Tamhane, A. Sevilla, A. et. al. Preventing Infectious Pulmonary Tuberculosis Among Foreign-Born Residents of the United States. Am J Public Health. 105(9):e81-e88.
32.
33.
Dara M, De Colombani P, Petrova-Benedict R, Centis R, Zellweger J-P, Sandgren A, et al. Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement. Eur Respir J. 2012;40(5):1081–90.CrossRef
34.
35.
Borgdorff MW, Van der Werf MJ, De Haas PE, Kremer K, Van Soolingen D. Tuberculosis elimination in the Netherlands. Emerg Infect Dis. 2005;11(4):597.CrossRef
36.
Bothamley GH, Kruijshaar ME, Kunst H, Woltmann G, Cotton M, Saralaya D, et al. Tuberculosis in UK cities: workload and effectiveness of tuberculosis control programmes. BMC Pub Health. 2011;11(1):896.CrossRef
37.
Kik SV, Olthof SP, de Vries JT, Menzies D, Kincler N, van Loenhout-Rooyakkers J, et al. Direct and indirect costs of tuberculosis among immigrant patients in the Netherlands. BMC Pub Health. 2009;9(1):283.CrossRef
38.
Spencer J, Lin M, Roche P, McKinnon M. Tuberculosis notifications in Australia, 2000. Commun Dis Intell Q Rep. 2002;26(2):214.PubMed
Metadata
Title
Tuberculosis treatment outcomes of non-citizen migrants: Israel compared to other high-income countries
Authors
D. Chemtob
E. Ogum
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Israel Journal of Health Policy Research / Issue 1/2020
Electronic ISSN: 2045-4015
DOI
https://doi.org/10.1186/s13584-020-00386-1

Other articles of this Issue 1/2020

Israel Journal of Health Policy Research 1/2020 Go to the issue

Original research article

Fear of panoptic surveillance: using digital technology to control the COVID-19 epidemic

Original research article

Physicians’ adherence to management guidelines for H. pylori infection and gastroesophageal reflux disease: a cross-sectional study

Commentary

Evaluating the consequences of health policy decisions

Editorial

Opportunities for diversifying and enriching our article mix

Perspective

Historic tobacco legislation in Israel: a moment to celebrate

Commentary

Digital governance in tax-funded European healthcare systems: from the Back office to patient empowerment